Shortage of 0.9% Sodium Chloride Injection
Areazine synthesizes this Health Canada drug-shortage notice directly from Drug Shortages Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
An active shortage of 0.9% Sodium Chloride Injection has been reported, with limited details available on manufacturers and status.
What this Health Canada drug-shortage notice tells you, and what most readers miss
This notice was issued by Drug Shortages Canada on April 7, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, 0.9% SODIUM CHLORIDE INJECTION.
Shortage of 0.9% Sodium Chloride Injection
As a professional health news writer for Areazine, I aim to provide factual information about drug shortages in an empathetic manner. This shortage may affect individuals who rely on this medication, and we encourage consulting healthcare providers for personalized guidance.
What's in Shortage
The drug in shortage is 0.9% Sodium Chloride Injection. No brand names or specific dosage forms beyond the injection reference in the name are provided in the available data. The current status is active, indicating an ongoing shortage.
Which Manufacturers Are Affected
No specific manufacturers are listed in the source data, so availability status and notes cannot be detailed.
Why There's a Shortage
No specific reason for the shortage has been provided in the source data.
What Patients Should Do
Patients experiencing issues with this medication should talk to their pharmacist or healthcare provider for advice. They may also ask about general options, but do not contact manufacturers as no contact information is available. Remember, patients should always consult their healthcare provider before making any changes, as this article does not provide medical advice.
Source
This information is attributed to the Drug Shortages Canada database, based on the provided source data. For more details, visit: https://healthproductshortages.ca/shortage/241158.
Original source: Drug Shortages Canada Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,423 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 7, 2026.
Frequently Asked Questions
Common questions about this Health Canada drug-shortage notice.